rather, in a phenome-wide analysis of people with type 2 diabetes, semaglutide prescription was associated with lower rates of diagnoses including candidiasis of vulva and vagina and inflammatory disease of cervix, vagina, and vulva compared with SGLT2 inhibitors, consistent with the known infection liability of SGLT2 inhibitors in women
Recent studies demonstrated that SGLT2i had cardioprotective effects in HFpEF (heart failure with preserved ejection fraction) and HFrEF (heart failure with reduced ejection fraction) with or without diabetes ( 5 Limitations The present study was associated with several limitations
Our 2025 study in JMIR Formative Research examined 12-month outcomes for participants using semaglutide with behavioural support and found 1 : 19.1% average weight loss at 12 months for active subscribers 77.7% achieved at least 10% weight loss 61.5% achieved at least 15% weight loss 69% reported no side effects by month 12 These are completer results (people who stayed on the programme for 12 months), not intent-to-treat
What does the article say about retatrutide's development status
In addition to its bioavailability and extended half life, rat liver microsomes were examined as an additional measurement of the effects of Dihexa on metabolic rate
